LEADER 02214nam  2200553   450 
001 9910811990803321
005 20230617003600.0
010   $a1-4698-7738-4
035   $a(CKB)2430000000022362
035   $a(EBL)3418712
035   $a(SSID)ssj0000353309
035   $a(PQKBManifestationID)11264820
035   $a(PQKBTitleCode)TC0000353309
035   $a(PQKBWorkID)10288550
035   $a(PQKB)10118067
035   $a(MiAaPQ)EBC2032532
035   $a(Au-PeEL)EBL2032532
035   $a(CaPaEBR)ebr10865274
035   $a(OCoLC)880453787
035   $a(EXLCZ)992430000000022362
100   $a20140508h20052005  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aMyoclonic epilepsies /$fPierre Genton [and six others], editors ; Anne M. Sydor, acquisition editor ; Scott Scheidt, developmental editor
205   $aFirst edition.
210  1$aPhiladelphia, Pennsylvania :$cLippincott Williams & Wilkins,$d2005.
210  4$dİ2005
215   $a1 online resource (304 p.)
225 1 $aAdvances in Neurology,$x0091-3952
300   $aDescription based upon print version of record.
311   $a0-7817-5248-5 
330   $a This volume is the first comprehensive text and clinical reference on idiopathic myoclonic epilepsies of infancy, childhood, adolescence, and adulthood. The world's foremost experts describe the phenotypes and subtypes of myoclonic epilepsies and the underlying molecular defects and summarize cutting-edge advances in molecular genetics that shed new light on the etiologies of these syndromes.   The book offers clinicians much-needed assistance in recognizing and diagnosing idiopathic myoclonic epilepsies and selecting appropriate treatment. Each chapter includes diagnostic and treatment algor
410  0$aAdvances in neurology.
606   $aEpilepsy
615  0$aEpilepsy.
676   $a616.853
702   $aGenton$b Pierre
702   $aSydor$b Anne M
702   $aScheidt$b Scott
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910811990803321
996   $aMyoclonic epilepsies$94110923
997   $aUNINA